Treating ST-elevation myocardial infarction

Area of Science:

• Cardiology
• Emergency Medicine

Background:

• Primary percutaneous coronary intervention (PCI) is the standard treatment for ST-elevation myocardial infarction (STEMI).
• Evidence supports superior long-term benefits of PCI over thrombolysis.
• Limited research exists on optimal treatment for STEMI patients presenting beyond 120 minutes.

Purpose of the Study:

• To review the pathophysiology of STEMI.
• To examine literature comparing primary PCI with thrombolysis followed by angiography.
• To highlight research gaps and encourage consideration of thrombolysis for late-presenting STEMI patients.

Main Methods:

• Literature review and case study analysis.
• Discussion of cardiovascular disease pathophysiology, acute coronary syndrome, and STEMI.
• Examination of comparative studies on primary PCI versus thrombolysis with angiography.

Main Results:

• Primary PCI is favored for STEMI, but its benefit in late presenters is less clear.
• Thrombolysis followed by angiography is a potential alternative for patients outside the standard time window.
• Gaps in evidence exist regarding the optimal strategy for late STEMI presentation.

Conclusions:

• Practitioners should consider thrombolysis for STEMI patients presenting after 120 minutes.
• Further research is warranted to establish the efficacy of thrombolysis followed by angiography in late STEMI presentations.
• Individualized treatment decisions are crucial for STEMI patients outside the recommended time frame.